Microalbuminuria and diabetic retinopathy in type 2 diabetic patients: From risk association to risk prediction.
作者信息
Chang Chia-Hsuin, Chuang Lee-Ming
机构信息
Department of Internal Medicine National Taiwan University Hospital Taipei Taiwan ; Institute of Preventive Medicine National Taiwan University School of Public Health Taipei Taiwan.
出版信息
J Diabetes Investig. 2013 Jan 29;4(1):42-4. doi: 10.1111/jdi.12023. Epub 2012 Dec 11.
Abstract
摘要
相似文献
1
Microalbuminuria and diabetic retinopathy in type 2 diabetic patients: From risk association to risk prediction.
J Diabetes Investig. 2013 Jan 29;4(1):42-4. doi: 10.1111/jdi.12023. Epub 2012 Dec 11.
2
Microalbuminuria and severity of diabetic retinopathy in type 1 diabetic patients: association and relationship with some risk factors.
Diabete Metab. 1995 Dec;21(6):440-5.
3
[Prospective study of correlation between diabetic retinopathy and microalbuminuria in diabetes type 1 patients].
Arch Soc Esp Oftalmol. 2000;75(5):307-14.
4
Left ventricular systolic function in selected type 1 diabetic patients with or without diabetic retinopathy and microalbuminuria.
Acta Clin Croat. 2014 Dec;53(4):383-9.
5
Relationship between diabetic retinopathy microalbuminuria and other modifiable risk factors.
Prim Care Diabetes. 2021 Jun;15(3):567-570. doi: 10.1016/j.pcd.2021.01.012. Epub 2021 Feb 4.
6
Diabetic retinopathy and microalbuminuria in lean type 2 diabetes mellitus.
J Assoc Physicians India. 2001 Apr;49:439-41.
7
[Relationship between microalbuminuria and diabetic retinopathy in type 1 diabetes mellitus].
Rev Clin Esp. 2000 Jul;200(7):351-4.
8
Microalbuminuria is associated with limited joint mobility in type I diabetes mellitus.
Ann Rheum Dis. 1995 Jul;54(7):582-6. doi: 10.1136/ard.54.7.582.
9
Systematic review on urine albumin testing for early detection of diabetic complications.
Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. doi: 10.3310/hta9300.
10
'Microalbuminuria' in type I (insulin-dependent) diabetic patients with and without retinopathy.
Acta Diabetol Lat. 1989 Apr-Jun;26(2):163-70. doi: 10.1007/BF02581368.
引用本文的文献
1
Fluoride enigma in end stage renal disease.
Bioinformation. 2024 Sep 30;20(9):998-1001. doi: 10.6026/973206300200998. eCollection 2024.
2
Neutrophil-Lymphocyte Ratio and Urine Albumin-Creatinine Ratio As Indicators of Microvascular Complications in Type 2 Diabetes Mellitus: A Cross-Sectional Study.
Cureus. 2024 Dec 6;16(12):e75196. doi: 10.7759/cureus.75196. eCollection 2024 Dec.
3
Association between albuminuria and retinal microvascular parameters measured with swept-source optical coherence tomography angiography in patients with diabetic retinopathy.
PLoS One. 2024 Mar 6;19(3):e0295768. doi: 10.1371/journal.pone.0295768. eCollection 2024.
4
Changes in diabetic and renal profile of people exposed to fluoride in south India.
Bioinformation. 2022 Sep 30;18(9):820-824. doi: 10.6026/97320630018820. eCollection 2022.
5
Disease Progression and Associations of Microvascular Complications in Diabetic Patients: A Study From South India.
Cureus. 2022 Oct 11;14(10):e30201. doi: 10.7759/cureus.30201. eCollection 2022 Oct.
6
Urinary Albumin to Creatinine Ratio to Predict Diabetic Retinopathy: The Eyes Have It!
Cureus. 2022 Mar 6;14(3):e22902. doi: 10.7759/cureus.22902. eCollection 2022 Mar.
7
Prevalence and Associated Factors of Diabetic Retinopathy among Type 2 Diabetes Mellitus Patients in Brunei Darussalam: A Cross-sectional Study.
Korean J Ophthalmol. 2022 Feb;36(1):26-35. doi: 10.3341/kjo.2021.0040. Epub 2021 Nov 8.
8
Incidence of Proliferative Diabetic Retinopathy and Other Neovascular Sequelae at 5 Years Following Diagnosis of Type 2 Diabetes.
Diabetes Care. 2021 Nov;44(11):2518-2526. doi: 10.2337/dc21-0228. Epub 2021 Sep 2.
9
Synergy between the pay-for-performance scheme and better physician-patient relationship might reduce the risk of retinopathy in patients with type 2 diabetes.
J Diabetes Investig. 2021 May;12(5):819-827. doi: 10.1111/jdi.13422. Epub 2020 Nov 7.
10
Early retinal neurodegeneration in preclinical diabetic retinopathy: a multifactorial investigation.
Eye (Lond). 2020 Jun;34(6):1100-1107. doi: 10.1038/s41433-019-0646-1. Epub 2019 Oct 25.
本文引用的文献
1
Should the hemoglobin A1c diagnostic cutoff differ between blacks and whites? A cross-sectional study.
Ann Intern Med. 2012 Aug 7;157(3):153-9. doi: 10.7326/0003-4819-157-3-201208070-00004.
2
A microalbuminuria threshold to predict the risk for the development of diabetic retinopathy in type 2 diabetes mellitus patients.
PLoS One. 2012;7(5):e36718. doi: 10.1371/journal.pone.0036718. Epub 2012 May 10.
3
More impact of microalbuminuria on retinopathy than moderately reduced GFR among type 2 diabetic patients.
Diabetes Care. 2012 Apr;35(4):803-8. doi: 10.2337/dc11-1955. Epub 2012 Feb 14.
4
Global prevalence and major risk factors of diabetic retinopathy.
Diabetes Care. 2012 Mar;35(3):556-64. doi: 10.2337/dc11-1909. Epub 2012 Feb 1.
5
Individual risk assessment and information technology to optimise screening frequency for diabetic retinopathy.
Diabetologia. 2011 Oct;54(10):2525-32. doi: 10.1007/s00125-011-2257-7. Epub 2011 Jul 27.
6
Prevalence of albuminuria and renal insufficiency and associated clinical factors in type 2 diabetes: the Japan Diabetes Clinical Data Management study (JDDM15).
Nephrol Dial Transplant. 2009 Apr;24(4):1212-9. doi: 10.1093/ndt/gfn603. Epub 2008 Nov 4.
7
Systematic review on urine albumin testing for early detection of diabetic complications.
Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. doi: 10.3310/hta9300.
Zotero 插件